Nachrichten zur Jazz Pharmaceuticals plc Aktie

Jazz Pharmaceuticals (JAZZ) Beats Q4 Earnings and Revenue Estimates

Jazz (JAZZ) delivered earnings and revenue surprises of +0.27% and +1.56%, respectively, for the quarter ended December 2025. Do the…

JAZZ Stock Rises as Q4 Earnings & Sales Top Expectations

Jazz Pharmaceuticals beats Q4 earnings and revenue estimates as neuroscience and oncology sales climb, sending shares up 5% in after…

Jazz Pharmaceuticals (JAZZ) Reports Next Week: Wall Street Expects Earnings Growth

Jazz (JAZZ) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report.…

Jazz Pharmaceuticals plc (JAZZ) Discusses HERIZON-GEA-01 Phase III Trial Results for Zanidatamab in HER2+ GEA Transcript

…

Jazz Pharmaceuticals stock falls after Phase 3 trial results By Investing.com

Jazz Pharmaceuticals stock falls after Phase 3 trial results…

Jazz Pharmaceuticals And Zymeworks Ziihera Success: A Pleasant Surprise

…

Jazz Pharmaceuticals (JAZZ) Reports Q2 Loss, Misses Revenue Estimates

Jazz (JAZZ) delivered earnings and revenue surprises of -34.80% and -0.26%, respectively, for the quarter ended June 2025. Do the…

Jazz Pharmaceuticals names Renee Gala as next CEO By Investing.com

Jazz Pharmaceuticals names Renee Gala as next CEO…

Jazz Pharmaceuticals (JAZZ) Q1 Earnings and Revenues Lag Estimates

Jazz (JAZZ) delivered earnings and revenue surprises of -62.75% and 8.52%, respectively, for the quarter ended March 2025. Do the…

Jazz Pharmaceuticals (JAZZ) Earnings Expected to Grow: Should You Buy?

Jazz (JAZZ) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming…

Akari Therapeutics Appoints Biotechnology Industry Leader, Abizer Gaslightwala, as President and Chief Executive Officer

Former SVP and Franchise Head for US Oncology at Jazz Pharmaceuticals, with established track record for leading a portfolio of…

Jazz Pharmaceuticals and Boston Beer Company have been highlighted as Zacks Bull and Bear of the Day

Jazz Pharmaceuticals and Boston Beer Company are part of the Zacks Bull and Bear of the Day article.…

Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio

-Dordaviprone addresses a significant unmet patient need for patients with rare, high-grade brain tumors-…

Zacks.com featured highlights include EverQuote, Jazz Pharmaceuticals, The Progressive, Sony and NatWest

EverQuote, Jazz Pharmaceuticals, The Progressive, Sony and NatWest have been highlighted in this Screen of The Week article.…

Jazz Pharmaceuticals (JAZZ) is a Top-Ranked Growth Stock: Should You Buy?

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.…

Jazz Pharmaceuticals: 60 % Kurspotenzial durch Rekordumsatz und gewonnenes Patentduell

Die Aktie von Jazz bleibt weiterhin hochinteressant. Im November 2024 berichtete ich sowohl an dieser Stelle als auch anschließend in…

Why Jazz Pharmaceuticals (JAZZ) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Heres why…

Jazz Pharmaceuticals plc 2024 Q4 - Results - Earnings Call Presentation

…

Jazz Pharmaceuticals (JAZZ) Tops Q4 Earnings and Revenue Estimates

Jazz (JAZZ) delivered earnings and revenue surprises of 13.99% and 2.57%, respectively, for the quarter ended December 2024. Do the…

ALX Oncology Announces New Data Demonstrating Evorpacept in Combination with Zanidatamab Generates Promising Antitumor Activity in Advanced Breast Cancer

SOUTH SAN FRANCISCO, Calif., Dec. 10, 2024 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. (“ALX Oncology” or “the…